載入...
Meta-analytical methods for estimating outcomes from overall response rate in patients with relapsed/refractory diffuse large B-cell lymphoma
Relapsed/refractory diffuse large B-cell lymphoma (DLBCL) is highly heterogeneous and current trials are investigating new approaches to improve outcomes. Limited data on response endpoints can confound estimation of a treatment effect when designing studies of novel agents in this setting, which ca...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6524929/ https://ncbi.nlm.nih.gov/pubmed/31143374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26904 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|